title: [Clinical study of a low-dose contraceptive--Femodene].
abstract: The authors present their clinical experience with a low-dose monophasic contraceptive consisting of 30 mcg ethinylestradiol and 75 mcg a gestagen--gestodene (Femoden, Schering). 112 menstrual cycles of 22 women in fertile age were followed. The results show 100% contraception, a good control of the menstrual cycle and tolerance of the preparation.
authors.forename: E
authors.initials: E
authors.lastname: Rachev
authors.forename: L
authors.initials: L
authors.lastname: Damianov
authors.forename: A
authors.initials: A
authors.lastname: Dukovski
authors.forename: M
authors.initials: M
authors.lastname: Katsarova
mesh_terms: D000328:Adult; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects; D009652:Norpregnenes / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology
chemical_list: D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D009652:Norpregnenes; C055368:Femovan; D004997:Ethinyl Estradiol
vernacular_title: Klinichno prouchvane na niskodoziran kontratseptiv--Femoden.